(Total Views: 299)
Posted On: 01/22/2020 8:52:41 AM
Post# of 149005
BTD said:
The data from the patient under the emergency IND protocol with HER2+ metastatic, stage 4, MBC showed no sign of new metastatic spots in the liver, lung and brain during the treatment with leronlimab.
Today's PR:
...showed a 50 percent shrinkage of the primary tumor and no new metastasis in the brain after treatment with leronlimab as a monotherapy."
--> tumor in liver and lung still there?
The data from the patient under the emergency IND protocol with HER2+ metastatic, stage 4, MBC showed no sign of new metastatic spots in the liver, lung and brain during the treatment with leronlimab.
Today's PR:
...showed a 50 percent shrinkage of the primary tumor and no new metastasis in the brain after treatment with leronlimab as a monotherapy."
--> tumor in liver and lung still there?
(2)
(0)Scroll down for more posts ▼
